Mylan/Upjohn cleared with remedies
Competition enforcers in New Zealand and Australia have cleared the proposed merger of Pfizer’s subsidiary Upjohn with Mylan subject to a series of divestitures.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.